Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. They are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.

Biotechnology

Biofourmis

Biofourmis' headquarters in Boston, MA, United States

David Koretz

Svp, Marketing & Growth Strategy

Raghu Mallena

Matt Lisowski

Andrew D. Zucker

Will Gray

Felix Pomerantz

Steve McKenzie

Maulik Majmudar

Daniel Song

Andrew Hedin

Jeff Clarke

Shane Chesson

Description

People (7)

Chris Loughnane

Howard Levy

Xiyu Zhang

Andrew D. Zucker

Andrew Chase

Thomas Demetriades

Andrew Hedin

Jobs